Abbott Laboratories 9MCY26 profit rises 25% to nearly Rs7bn
Net profit rose 24.57% year-on-year to Rs6.68bn for the nine months ended September 30, 2026, from Rs5.37bn in the same period last year, as higher local sales, lower cost of sales and a bigger gross profit lifted Abbott Laboratories (Pakistan) Limit
October 27, 2026 (MLN): Net profit rose 24.57% year-on-year to Rs6.68bn for the nine months ended September 30, 2026, from Rs5.37bn in the same period last year, as higher local sales, lower cost of sales and a bigger gross profit lifted Abbott Laboratories (Pakistan) Limited (PSX: ABOT). Basic and diluted earnings per share (EPS) increased 24.58% to Rs68.28, compared with Rs54.81 a year earlier. Net sales grew 4.32...